The Food and Drug Administration (FDA) has issued warning letters to five manufacturers of dietary supplements due to the listing of R-beta-methylphenethylamine (also known as Beta-methylphenethylamine, βMePEA, or BMPEA) on the product label.
BMPEA is not considered to be a dietary ingredient within the definition set forth in the Federal Food, Drug, and Cosmetic Act and is not approved as a food additive or prior sanctioned for use in dietary supplements. The FDA’s review of this substance does not identify a basis to conclude the substance is Generally Recognized as Safe (GRAS) for use in food. The FDA states that declaring BMPEA on product labeling as a dietary ingredient causes the product to be misbranded with a false or misleading label if marketed as a dietary supplement. BMPEA is an unapproved amphetamine-like substance that has been shown to increase blood pressure and heart rates in dogs and cats.
RELATED: New Warning From FDA on Unapproved Drugs in Sex Enhancement Supplement
The products that list BMPEA on the product label include:
- Conquer (Fruit Punch Slam and Raspberry Lemonade flavors)
- Core Burner Watermelon powder
- Critical FX
- Fastin-XR
- Fastin Rapid Release
- Lipodrene Extended Release
- Phoenix Extreme Blend
- Sudden Impact
